Four posters presenting research conducted by PHAR, LLC in collaboration with Eisai Inc. were featured at the Multinational Association of Supportive Care in Cancer 2011 International Symposium in Athens, Greece. Investigators examined the risks of chemotherapy-induced nausea and vomiting (CINV) following the use of several chemotherapy regimens and the costs associated with CINV.
Archives for June 2011
PHAR Study Examines How Obesity and Health Vary by Race and Gender
PHAR investigators used nine health-related quality of life (HRQoL) measures to study how HRQoL varies by body mass index category among gender and racial subgroups. The research found that a lower HRQoL score was associated with being obese or overweight rather than with having a normal body mass index. The associations were driven primarily by physical health. The degree of the associations varied by the index used. PHAR, LLC investigators collaborated with the RAND Corporation, University of Wisconsin-Madison School of Medicine and Public Health, UCLA School of Public Health, Kaiser Permanente Northwest Region, and Health Utilities Inc. For more detailed results, visit the Quality of Life Research website.
Impact of Adherence to Pulmozyme® Treatment on Health Status and Costs
Using a retrospective cohort analysis, PHAR, LLC investigators collaborated with researchers at the University of Michigan and Genentech, Inc. to study adherence to Pulmozyme® in patients with cystic fibrosis. The findings were presented at the 34th European Cystic Fibrosis Society Conference.